Type 1 diabetes

Following the science of a cure

Insulin-producing cells grown from stem cells. Cells the immune system can't see. Drugs that stop the attack before it starts. All three are in human trials now. This site tracks how close they are, with sources and dates.

The road to a cure Research tracker

Research

The road to a cure

The two problems a cure must solve, the approaches that try, and what has to happen, in order.

Research tracker

Every major program: phase, latest result, next milestone and sources.

Uppsala's world first: islets the immune system ignores

In 2025 a team in Uppsala showed that gene-edited islet cells can survive in a person with type 1 diabetes without immunosuppression. What was done, what it shows, and what Sweden needs for the next step.

Teaching the immune system to stop

New cells aren't enough: the immune system remembers beta cells and attacks them again. Hiding the cells is one answer. Teaching the immune system tolerance is the other, and much of the progress comes from other autoimmune diseases.

Until the cure: the closed loop, part by part

Pumps and sensors are a bridge until biology takes over. A map of the closed loop, from inputs to the human in it, and where each part is limited today.

Sweden: who works on a cure

The research groups, companies and funders in Sweden working toward a cure for type 1 diabetes, and the gap between world-leading results and the industry needed to bring them to patients.

China: fast trials, few published results

China runs many of the world's early cell- and immune-therapy trials for type 1 diabetes. A look at the rules, the programs, and how they compare with the results from Uppsala.

Unproven stem-cell treatments: warning signs

Clinics and companies sell stem-cell and immune 'cures' for type 1 diabetes outside proper trials. How to tell real research from a commercial offer.

From the blog

2026-11-11
Control-IQ+ often corrects when the rise is already over
In 103 automatic corrections over six weeks of our child's pump data, most post-meal corrections came the minute a one-hour lockout ended, when the rise had usually slowed and often stopped. What we found, and why it matters for small children.
2026-11-11
Parents of small children need real follow apps
The Tandem Mobi has no way for a parent to follow pump data in real time, and Dexcom's Follow app leaves out the alerts that matter most when glucose drops fast. For a young child, the follower is the person who acts.

All posts